STI 1557
Alternative Names: STI-1557Latest Information Update: 26 Dec 2022
At a glance
- Originator Sorrento Therapeutics
- Class COVID-19 vaccines; Protein vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical COVID 2019 infections